• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在乳糜泻中,单独的阳性脱酰胺麦胶蛋白 IgG 具有有限的诊断实用性。

Isolated positive deamidated gliadin peptide-IgG has limited diagnostic utility in coeliac disease.

机构信息

Department of Paediatrics, Monash University, Melbourne, Victoria, Australia.

出版信息

J Paediatr Child Health. 2022 Sep;58(9):1648-1652. doi: 10.1111/jpc.16071. Epub 2022 Jun 21.

DOI:10.1111/jpc.16071
PMID:35726522
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9545789/
Abstract

AIM

Deamidated gliadin peptide-IgG (DGP-IgG) antibody serology testing is widely utilised in screening for coeliac disease in Australia; however, it is used sparingly in Europe. The aim of this study was to assess the diagnostic value of a positive DGP-IgG in the setting of a negative tissue transglutaminase-IgA (tTG-IgA) for gastrointestinal pathology among paediatric patients.

METHODS

We conducted a retrospective cohort study of all children with an elevated DGP-IgG in the setting of a negative tTG-IgA who underwent gastroscopy over a 48-month period (January 2015-December 2018) at a tertiary paediatric centre. They were identified utilising the electronic pathology database and demographic and clinical data were collected from electronic medical records. Patients who had previously been diagnosed with coeliac disease were on a gluten-free diet or over the age of 18 were excluded from the study.

RESULTS

Twenty-six patients with an elevated DGP-IgG in the setting of a negative tTG-IgA underwent gastroscopy. Our study yielded a positive predictive value of 1/26 (3.9% CI 95% 0.7%, 18.9%) for the diagnosis of coeliac disease. Overall, there were 25 histopathological diagnoses including 1 diagnosis of coeliac disease among the total 26 patients who were positive DGP-IgG and negative tTG-IgA and underwent gastroscopy.

CONCLUSIONS

Our findings suggest that an isolated positive DGP-IgG has a very low diagnostic yield for coeliac disease in children and may be indicative of other gastrointestinal pathology.

摘要

目的

脱酰胺麦谷蛋白肽 IgG(DGP-IgG)抗体血清学检测在澳大利亚被广泛用于筛查乳糜泻;然而,在欧洲却很少使用。本研究旨在评估在组织转谷氨酰胺酶 IgA(tTG-IgA)阴性的情况下,阳性 DGP-IgG 对儿科患者胃肠道病理的诊断价值。

方法

我们对在 48 个月期间(2015 年 1 月至 2018 年 12 月)在一家三级儿科中心接受内窥镜检查的所有 DGP-IgG 升高且 tTG-IgA 阴性的儿童进行了回顾性队列研究。他们是通过电子病理学数据库识别的,从电子病历中收集了人口统计学和临床数据。已被诊断患有乳糜泻的患者或已接受无麸质饮食或年龄超过 18 岁的患者被排除在研究之外。

结果

26 例 DGP-IgG 升高且 tTG-IgA 阴性的患者接受了内窥镜检查。我们的研究得出的阳性预测值为 1/26(3.9%置信区间 95%为 0.7%,18.9%),用于诊断乳糜泻。总体而言,在 26 例 DGP-IgG 阳性且 tTG-IgA 阴性并接受内窥镜检查的患者中,有 25 例组织病理学诊断,包括 1 例乳糜泻诊断。

结论

我们的研究结果表明,孤立的阳性 DGP-IgG 对儿童乳糜泻的诊断率非常低,可能提示其他胃肠道病理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a0/9545789/ba3f651913b3/JPC-58-1648-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a0/9545789/bb605e863f9a/JPC-58-1648-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a0/9545789/ba3f651913b3/JPC-58-1648-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a0/9545789/bb605e863f9a/JPC-58-1648-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a0/9545789/ba3f651913b3/JPC-58-1648-g002.jpg

相似文献

1
Isolated positive deamidated gliadin peptide-IgG has limited diagnostic utility in coeliac disease.在乳糜泻中,单独的阳性脱酰胺麦胶蛋白 IgG 具有有限的诊断实用性。
J Paediatr Child Health. 2022 Sep;58(9):1648-1652. doi: 10.1111/jpc.16071. Epub 2022 Jun 21.
2
Usefulness of deamidated gliadin peptide antibodies in diagnosing coeliac disease in children younger than 3 years old.去酰胺化麦醇溶蛋白肽抗体在诊断3岁以下儿童乳糜泻中的应用价值。
J Paediatr Child Health. 2022 May;58(5):815-819. doi: 10.1111/jpc.15845. Epub 2021 Dec 6.
3
Deamidated gliadin peptide and tissue transglutaminase antibodies in children with coeliac disease: A correlation study.麸质敏感患儿中脱酰胺麦胶蛋白肽和组织转谷氨酰胺酶抗体:相关性研究。
Arab J Gastroenterol. 2020 Sep;21(3):174-178. doi: 10.1016/j.ajg.2020.07.001. Epub 2020 Jul 28.
4
To DGP-IgG or not? a comparison of TTG-IgA and DGP-IgG.是否检测 DGP-IgG?对比 TTG-IgA 和 DGP-IgG。
Clin Chim Acta. 2022 Jun 1;531:382-385. doi: 10.1016/j.cca.2022.05.008. Epub 2022 May 10.
5
IgA anti-tissue transglutaminase antibodies and IgG antibodies against deamidated gliadin peptides as predictors of celiac disease.抗组织转谷氨酰胺酶IgA抗体和抗脱酰胺麦醇溶蛋白肽IgG抗体作为乳糜泻的预测指标
Arch Argent Pediatr. 2019 Feb 1;117(1):52-55. doi: 10.5546/aap.2019.eng.52.
6
Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease.用于儿童乳糜泻诊断的抗合成脱酰胺麦醇溶蛋白肽和组织转谷氨酰胺酶抗体。
Clin Gastroenterol Hepatol. 2007 Nov;5(11):1276-81. doi: 10.1016/j.cgh.2007.05.024. Epub 2007 Aug 1.
7
Diagnostic utility of deamidated gliadin peptide antibody in celiac disease compared to anti-tissue transglutaminase and IgA- endomysium antibodies.与抗组织转谷氨酰胺酶抗体和IgA-肌内膜抗体相比,脱酰胺麦醇溶蛋白肽抗体在乳糜泻中的诊断效用。
Egypt J Immunol. 2012;19(2):41-52.
8
Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients.抗脱酰胺麦胶蛋白肽 IgG 抗体对儿童和 IgA 缺乏患者乳糜泻的诊断价值。
J Pediatr Gastroenterol Nutr. 2012 Jul;55(1):50-5. doi: 10.1097/MPG.0b013e31824703c7.
9
Deamidated Gliadin Antibodies: Do They Add to Tissue Transglutaminase-IgA Assay in Screening for Celiac Disease?脱酰胺麦胶蛋白抗体:在乳糜泻的筛查中,它们是否会增加组织转谷氨酰胺酶-IgA 检测?
J Pediatr Gastroenterol Nutr. 2021 May 1;72(5):e112-e118. doi: 10.1097/MPG.0000000000003022.
10
In Screening for Celiac Disease, Deamidated Gliadin Rarely Predicts Disease When Tissue Transglutaminase Is Normal.在乳糜泻的筛查中,当组织转谷氨酰胺酶正常时,脱酰胺麦胶蛋白很少能预测疾病。
J Pediatr Gastroenterol Nutr. 2019 Jan;68(1):20-25. doi: 10.1097/MPG.0000000000002109.

引用本文的文献

1
Performance of deamidated gliadin peptide antibodies as first screening for celiac disease in the general pediatric population.脱酰胺麦醇溶蛋白肽抗体在普通儿科人群中作为乳糜泻初筛的性能。
Front Pediatr. 2023 Nov 21;11:1279825. doi: 10.3389/fped.2023.1279825. eCollection 2023.

本文引用的文献

1
European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020.欧洲儿科胃肠病学、肝病学和营养学学会 2020 年乳糜泻诊断指南。
J Pediatr Gastroenterol Nutr. 2020 Jan;70(1):141-156. doi: 10.1097/MPG.0000000000002497.
2
European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders.欧洲乳糜泻研究学会(ESsCD)乳糜泻和其他相关麸质疾病指南。
United European Gastroenterol J. 2019 Jun;7(5):583-613. doi: 10.1177/2050640619844125. Epub 2019 Apr 13.
3
In Screening for Celiac Disease, Deamidated Gliadin Rarely Predicts Disease When Tissue Transglutaminase Is Normal.
在乳糜泻的筛查中,当组织转谷氨酰胺酶正常时,脱酰胺麦胶蛋白很少能预测疾病。
J Pediatr Gastroenterol Nutr. 2019 Jan;68(1):20-25. doi: 10.1097/MPG.0000000000002109.
4
Interpreting tests for coeliac disease: Tips, pitfalls and updates.解读乳糜泻检测:技巧、陷阱和更新。
Aust J Gen Pract. 2018 Jan-Feb;47(1-2):28-33. doi: 10.31128/AFP-10-17-4357.
5
Diagnostic Yield of Isolated Deamidated Gliadin Peptide Antibody Elevation for Celiac Disease.孤立性脱酰胺麦醇溶蛋白肽抗体升高对乳糜泻的诊断价值
Dig Dis Sci. 2017 May;62(5):1272-1276. doi: 10.1007/s10620-017-4474-5. Epub 2017 Feb 4.
6
Interpretation of serological tests in the diagnosis of celiac disease: Anti-deamidated gliadin peptide antibodies revisited.血清学检测在乳糜泻诊断中的解读:重新审视抗去酰胺麦醇溶蛋白多肽抗体
Autoimmunity. 2016 Sep;49(6):414-420. doi: 10.1080/08916934.2016.1203908. Epub 2016 Jul 23.
7
Screening for celiac disease in Danish adults.丹麦成年人乳糜泻的筛查
Scand J Gastroenterol. 2015 Jul;50(7):824-31. doi: 10.3109/00365521.2015.1010571. Epub 2015 Feb 17.
8
Early and correct diagnosis of celiac disease in the prevention of growth disorders and child development.
Mater Sociomed. 2012;24(4):242-7. doi: 10.5455/msm.2012.24.242-247.
9
Antibodies against deamidated gliadin peptides and tissue transglutaminase for diagnosis of pediatric celiac disease.抗脱酰胺麦胶多肽和组织转谷氨酰胺酶抗体用于儿童乳糜泻的诊断。
J Pediatr Gastroenterol Nutr. 2012 Dec;55(6):695-700. doi: 10.1097/MPG.0b013e3182645c54.
10
The Oslo definitions for coeliac disease and related terms.奥胡斯定义:乳糜泻及相关术语
Gut. 2013 Jan;62(1):43-52. doi: 10.1136/gutjnl-2011-301346. Epub 2012 Feb 16.